ORIZURU THERAPEUTICS INC.: Regenerative Medicine and Drug Discovery using iPS technology

Top 5 Biotech Startups in South Korea - 2022

Currently, biotechnology startups place a greater emphasis on automation and computer-aided drug development. The most recent industry trends include the incorporation of AI, the development of personalized medicine, an increase in digital diagnosis, and a greater emphasis on immune cell functions.

The global Biotechnology services market was estimated at US$ 129.15 billion in 2021 and has grown at a compound annual growth rate (CAGR) of 15.6% to US$ 149.32. These trends have contributed to the potential for a sizable market for companies to invest further in the biotechnology startup sector.

This issue of Startup City features the ‘Top 5 Biotech startups in Japan - 2022’ which highlights some of the most important developments in the Japanese biotechnology space, as well as how biotechnology startups are operating in the current business environment and how they improve productivity and profitability.

The edition also includes a list of the ‘Top 10 Biotech Startups in APAC,’ highlighting the trends and developments in biotechnology startups throughout the Asia-Pacific region.

Furthermore, it includes the ‘Top 5 Biotech Startups in Singapore - 2022’ and ‘Top 5 Biotech Startups in South Korea - 2022’ which go into greater detail about the characteristics, trends, and developments of biotechnology startups in the respective regions.

It includes companies such as Orizuru Therapeutics, which was founded in 2021 as collaboration between Kyoto University and Takeda Pharmaceutical Company to research and commercialize iPS cell-based medicines. It is primarily concerned with cell regeneration therapy, regenerative medicine products derived from cell transplantation, and medication development.

The magazine also highlights the opinions of Michael Krel, Partner, Industrial Biotech Strategy, Sofinnova Partners, and Dr. Dan Liu, Partner in Venture and Growth Capital, CDH Investments. They respectively discuss the biotechnology industry’s evolution, challenges, and future, as well as how the industry is shaping up in China’s currently volatile business environment.

Write to us about how Biotechnology has assisted in the functioning of your organizations!

    Top Biotech Startups in South Korea

    Glory Biotechnologiesis an expert innovative research and development company dedicated to the development of new diagnostics systems for the diagnosis of incurable diseases and providing a complete solution for the biotechnology Industry. ... read full profile
    SB Bioscience was established with the goal of becoming the top biotech company in the field of new drugs and diagnostics using aptamers. The firm has the technology to discover aptamers and is also building an aptamer library used for antibody-aptamer (Sandwich Assay). ... read full profile
    iN Therapeutics
    iN Therapeutics is a spin-off biotech, from a leading local pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for an ion channel, Nav1.7 non-opioid analgesic, and treatments for hearing loss and neurological diseases
    ImmuneOncia Therapeutics Inc.
    ImmuneOncia Therapeutics Inc. is an immunooncology- centric biopharmaceutical company. Established in 2016 as a joint venture company between Yuhan (51%) and Sorrento (49%), ImmuneOncia will leverage both companies’ expertise in drug development and antibody engineering. Their mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide
    MYCEL
    Mycel Project develops and manufactures a wide range of biomaterials that can be used to substitute leather and flesh